Femto Technologies FMTOF

Femto Technologies Inc. develops and commercializes medical devices and software solutions primarily targeting women's health and business management sectors. The company operates through its Israeli subsidiary BYND—Beyond Solutions Ltd., which focuses on customer relationship management software, and through its ownership of the Sensera device, a patent-pending AI-powered biofeedback system designed to regulate lubricant flow into female soft tissues. All business activities are conducted in Israel, with revenue generated domestically.

Revenue is generated primarily through the licensing and customization of Benefit CRM software for small and medium-sized businesses, including license sales, customization fees, cloud backup services, training sessions, and SMS and credit card clearing services. Additional revenue streams include potential future sales of the Sensera device and associated lubricant capsules under a razors-and-blades business model, though current Sensera-related revenue is minimal as the device remains in early commercialization. The company also explores opportunities in medical cannabis trading through a contactless license, though this activity is currently inactive.

The company operates through the following segments:

• Software: This segment encompasses the development, marketing, and sale of Benefit CRM software and its newer iterations, including the New CRM Platform and New Cannabis CRM Platform. The Benefit CRM software enables small and medium-sized businesses to optimize sales management, personnel management, marketing, call center activities, and asset management. The New CRM Platform migrates the software to a cloud-based service, allowing clients and resellers to create customized CRM solutions for resale, while the New Cannabis CRM Platform is designed for medical cannabis cultivation with real-time environmental monitoring, automated irrigation, inventory tracking, and AI-powered analytics. The segment includes trademarked names such as Benefit CRM, New CRM Platform, and New Cannabis CRM Platform.
• Sensera Device: This segment involves the development and commercialization of the Sensera device, a unique, patent-pending AI-based biofeedback system that regulates lubricant and oil flow into the soft tissues of the female sexual organs. The device features an internal pump and Smart Release System (SRS) activated by humidity and friction sensors, working in synergy with an iOS app that collects biometric data to personalize treatment plans. The Sensera device has earned recognition as an Innovation Awards Honoree at CES 2025 in the Artificial Intelligence category. Associated trademarks and patented technologies include the Smart Release System (SRS), the ergonomic Y-shaped design, and the Sensera wellness brand.

The company holds a niche position in two distinct markets: in the Israeli CRM software space, it competes with larger global providers such as SAP SE, Oracle Corporation, Salesforce.com, LLC, Microsoft Corporation, Pivotal Software Inc., and local competitor Eshbel Technologies, differentiating itself through flexibility and customization for small and medium-sized businesses; in the women's health technology sector, the Sensera device faces no direct competitors offering similar AI-regulated lubricant delivery for female soft tissue wellness, positioning Femto Technologies as a potential first-mover in this emerging femtech subsegment.

The company serves small and medium-sized businesses across various industries in Israel for its CRM software offerings, with over 400 organizations using the Benefit CRM software as of fiscal 2025, including a major concentration of revenue from Harel Insurance Company Ltd. For the Sensera device, the target market consists of individual consumers seeking sexual wellness and therapeutic solutions, marketed through direct-to-consumer digital channels, influencer and affiliate programs, with planned future expansion via Amazon shop.